Allergic rhinitis behavioral changes after Indonesian house dust mites allergenic extract administration as immunotherapy

Authors

  • Yusuf Alif Pratama Master Program of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Honey Dzikri Marhaeny Master Program of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Lutfiatur Rohmah Bachelor Program of Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Salsabilla Madudari Kasatu Bachelor Program of Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Ahmad Dzulfikri Nurhan Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Mahardian Rahmadi Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya
  • Junaidi Khotib Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya

DOI:

https://doi.org/10.4081/jphia.2023.2510

Keywords:

Desensitization, IHDM, neglected disease, phenotype, sneezing

Abstract

Background: Allergy is a hypersensitivity reaction that is generally mediated by Immunoglobulin E (IgE). More than 25% of the world’s population is suspected of having these various diseases, and the prevalence and progression of these diseases have continued to increase significantly in recent years. Among these allergy-related diseases, allergic rhinitis and food allergy are the types of allergies with the highest prevalence. Clinical manifestations of allergic rhinitis include sneezing, rhinorrhea, nasal itching, and nasal congestion.

Objective: This study aimed to determine the behavioral changes of allergic rhinitis after Indonesian House Dust Mites (IHDM) allergenic extract administration as an immunotherapy.

Methods: Eight male BALB/c mice aged 6-8 weeks in each group were treated for seven groups. The sensitization phase is given intraperitoneal, the desensitization phase is given by subcutaneous, and the challenge phase is given intranasal. The allergic parameters were observed, such as nose rubbing and sneezing. The parameters were observed for 15 minutes after the challenge administration.

Results: The results showed that the administration of Indonesian House Dust Mites as immunotherapy decreased the frequency of nose rubbing and sneezing after the administration of immunotherapy compared to the allergic rhinitis model.

Conclusions: The administration of the Indonesia House Dust Mites as immunotherapy decreased the allergic rhinitis immune response by altering the behavioral parameter.

Download data is not yet available.

References

Calzada D, Baos S, Cárdaba B. Review Article Immunological Mechanisms in Allergic Diseases and Allergen Tolerance: The Role of Treg Cells. J Immunol Res. 2018;2018:6012053. DOI: https://doi.org/10.1155/2018/6012053

Lou H, Huang Y, Ouyang Y, et al. Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial. Allergy Eur J Allergy Clin Immunol. 2020;75:2022–32. DOI: https://doi.org/10.1111/all.14218

Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of Allergen Immunotherapy in Allergic Rhinitis. Curr Allergy Asthma Rep. 2021;21:1–17. DOI: https://doi.org/10.1007/s11882-020-00977-7

Wang YC, Jaakkola MS, Lajunen TK, et al. Asthma-COPD Overlap Syndrome among subjects with newly diagnosed adult-onset asthma. Allergy Eur J Allergy Clin Immunol. 2018;73:1554–7. DOI: https://doi.org/10.1111/all.13459

Sultész M, Horváth A, Molnár D, et al. Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren. Allergy, Asthma Clin Immunol. 2020;16:1–11. DOI: https://doi.org/10.1186/s13223-020-00495-1

Ologe FE, Adebola SO, Dunmade AD, et al. Symptom score for allergic rhinitis. Otolaryngol - Head Neck Surg (United States). 2013;148:557–63. DOI: https://doi.org/10.1177/0194599813477605

Pawankar R, Hayashi M, Yamanishi S, Igarashi T. The paradigm of cytokine networks in allergic airway inflammation. Curr Opin Allergy Clin Immunol. 2015;15:41–8. DOI: https://doi.org/10.1097/ACI.0000000000000129

Eifan AO, Calderon MA, Durham SR. Allergen immunotherapy for house dust mite: Clinical efficacy and immunological mechanisms in allergic rhinitis and asthma. Expert Opin Biol Ther. 2013;13:1543–56. DOI: https://doi.org/10.1517/14712598.2013.844226

Calderón MA, Kleine-Tebbe J, Linneberg A, et al. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies. J Allergy Clin Immunol Pract. 2015;3:843–55. DOI: https://doi.org/10.1016/j.jaip.2015.06.019

Meng Y, Wang C, Zhang L. Recent developments and highlights in allergic rhinitis. Allergy Eur J Allergy Clin Immunol. 2019;74:2320–8. DOI: https://doi.org/10.1111/all.14067

Khotib J, Utami NW, Gani MA, Ardianto C. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis. J Basic Clin Physiol Pharmacol. 2019;30:1–8. DOI: https://doi.org/10.1515/jbcpp-2019-0331

Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: An update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11:1646–62. DOI: https://doi.org/10.1016/j.intimp.2011.07.005

Gani M, Nurhan A, Maulana S, et al. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2. J Adv Pharm Technol Res. 2021;12:120–6.

Husain S, Zahedi FD, Mohamad S, Abdullah B. House Dust Mite-Induced Allergic Rhinitis: Is Prevention an Option? Curr Treat Options Allergy. 2019;6:338–49. DOI: https://doi.org/10.1007/s40521-019-00225-y

Wills-Karp M, Nathan A, Page K, Karp CL. New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol. 2010;3:104–10. DOI: https://doi.org/10.1038/mi.2009.138

Kim LK, Morita R, Kobayashi Y, et al. AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites. Proc Natl Acad Sci U S A. 2015;112:E2891–9. DOI: https://doi.org/10.1073/pnas.1507393112

Miller JD. The Role of Dust Mites in Allergy. Clin Rev Allergy Immunol. 2019;57:312–29. DOI: https://doi.org/10.1007/s12016-018-8693-0

Van Dyken SJ, Garcia D, Porter P, et al. Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. J Immunol. 2011;187:2261–7. DOI: https://doi.org/10.4049/jimmunol.1100972

Van Dyken SJ, Liang H-E, Naikawadi RP, et al. Spontaneous chitin accumulation in airways and age-related fibrotic lung disease. Cell. 2017;169:497–509. DOI: https://doi.org/10.1016/j.cell.2017.03.044

Klimek L, Bachert C, Pfaar O, et al. ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergo J Int. 2019;28:255–76. DOI: https://doi.org/10.1007/s40629-019-00110-9

Hossenbaccus L, Linton S, Garvey S, Ellis AK. Towards definitive management of allergic rhinitis: Best use of new and established therapies. Allergy, Asthma Clin Immunol. 2020;16:1–17. DOI: https://doi.org/10.1186/s13223-020-00436-y

Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288-1296.e3. DOI: https://doi.org/10.1016/j.jaci.2013.01.049

Globinska A, Boonpiyathad T, Satitsuksanoa P, et al. Mechanisms of allergen-specific immunotherapy - Diverse mechanisms of immune tolerance to allergens. 2018;121:306–12. DOI: https://doi.org/10.1016/j.anai.2018.06.026

Lee K, Lee SH, Kim TH. The biology of prostaglandins and their role as a target for allergic airway disease therapy. Int J Mol Sci. 2020;21:1851. DOI: https://doi.org/10.3390/ijms21051851

Small P, Keith PK, Kim H. Allergic rhinitis. Allergy, Asthma Clin Immunol. 2018;14:1–11. DOI: https://doi.org/10.1186/s13223-018-0280-7

Bjermer L, Westman M, Holmström M, Wickman MC. The complex pathophysiology of allergic rhinitis: Scientific rationale for the development of an alternative treatment option. Allergy, Asthma Clin Immunol. 2019;15:1–15. DOI: https://doi.org/10.1186/s13223-018-0314-1

Palomares O, Akdis M, Martín-Fontecha M, Akdis CA. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017;278:219–36. DOI: https://doi.org/10.1111/imr.12555

Huang FL, Liao EC, Yu SJ. House dust mite allergy: Its innate immune response and immunotherapy. Immunobiology. 2018;223:300–2. DOI: https://doi.org/10.1016/j.imbio.2017.10.035

Shinmei Y, Yano H, Kagawa Y, et al. Effect of Brazilian propolis on sneezing and nasal rubbing in experimental allergic rhinitis of mice. Immunopharmacol Immunotoxicol. 2009;31:688–93. DOI: https://doi.org/10.3109/08923970903078443

Aswar U, Shintre S, Chepurwar S, Aswar M. Antiallergic effect of piperine on ovalbumin-induced allergic rhinitis in mice. Pharm Biol. 2015;53:1358–66. DOI: https://doi.org/10.3109/13880209.2014.982299

Shi Z, Jiang W, Chen X, et al. Chlorogenic acid ameliorated allergic rhinitis-related symptoms in mice by regulating Th17 cells. Biosci Rep. 2020;40:1–11. DOI: https://doi.org/10.1042/BSR20201643

Jung HJ, Ko YK, Shim WS, et al. Diesel exhaust particles increase nasal symptoms and IL-17A in house dust mite-induced allergic mice. Sci Rep. 2021;11:1–9. DOI: https://doi.org/10.1038/s41598-021-94673-9

Son HL, Park HR, Park YJ, Kim SW. Effect of retinoic acid in a mouse model of allergic rhinitis. Allergy, Asthma Immunol Res. 2015;7:590–8. DOI: https://doi.org/10.4168/aair.2015.7.6.590

Ko MT, Huang SC, Kang HY. Establishment and characterization of an experimental mouse model of allergic rhinitis. Eur Arch Oto-Rhino-Laryngology. 2015;272:1149–55. DOI: https://doi.org/10.1007/s00405-014-3176-2

Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017;140:1485–98. DOI: https://doi.org/10.1016/j.jaci.2017.10.010

Matsuoka T, Shamji MH, Durham SR. Allergen immunotherapy and tolerance. Allergol Int. 2013;62:403–13. DOI: https://doi.org/10.2332/allergolint.13-RAI-0650

Joudi M, Hosseini RF, Khoshkhui M, et al. Effects of serum Vitamin D and efficacy of subcutaneous immunotherapy in adult patients with allergic rhinitis. Allergy, Asthma Immunol Res. 2019;11:885–93. DOI: https://doi.org/10.4168/aair.2019.11.6.885

Lundberg K, Rydnert F, Broos S, et al. Allergen-specific immunotherapy alters the frequency, as well as the FcR and CLR expression profiles of human dendritic cell subsets. PLoS One. 2016;11:1–13. DOI: https://doi.org/10.1371/journal.pone.0148838

Agache I, Lau S, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy Eur J Allergy Clin Immunol. 2019;74:855–73. DOI: https://doi.org/10.1111/all.13749

Okubo K, Kurono Y, Ichimura K, et al. Japanese guidelines for allergic rhinitis 2020. Allergol Int. 2020;69:331–45. DOI: https://doi.org/10.1016/j.alit.2020.04.001

Downloads

Published

16-03-2023

How to Cite

Pratama, Y. A., Marhaeny, H. D., Rohmah, L., Kasatu, S. M., Nurhan, A. D., Rahmadi, M., & Khotib, J. (2023). Allergic rhinitis behavioral changes after Indonesian house dust mites allergenic extract administration as immunotherapy. Journal of Public Health in Africa, 14(s1). https://doi.org/10.4081/jphia.2023.2510